28325-56-6
Chemical Structure
IVHD-valtrate
- CAS No.: 28325-56-6
- Formula:C27H40O11
- Molecular Weight:540.60
IUPAC Name: ((1S,4aR,6S,7R,7aS)-6-acetoxy-4a-hydroxy-1-((3-methylbutanoyl)oxy)-4a,5,6,7a-tetrahydro-1H-spiro[cyclopenta[c]pyran-7,2'-oxiran]-4-yl)methyl 3-methyl-2-((3-methylbutanoyl)oxy)butanoate
InChIKey: QPMVBTMUWDUUTJ-KZYULCMASA-N
SMILES: CC(O[C@@H](C1)[C@]2(CO2)[C@]([C@@H]3OC(CC(C)C)=O)([H])[C@]1(C(COC(C(C(C)C)OC(CC(C)C)=O)=O)=CO3)O)=O
Biological Activity: IVHD-valtrate, an active Valeriana jatamansi derivative, is against human ovarian cancer cells in vitro and in vivo. IVHD-valtrate induces cancer cells apoptosis and arrests the ovarian cancer cells in the G2/M phase. IVHD-valtrate has the potential to be a novel chemotherapeutic agent for the human ovarian cancer research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
IVHD-valtrate | IVHD-valtrate, an active Valeriana jatamansi derivative, is against human ovarian cancer cells in vitro and in vivo. IVHD-valtrate induces cancer cells apoptosis and arrests the ovarian cancer cells in the G2/M phase. IVHD-valtrate has the potential to be a novel chemotherapeutic agent for the human ovarian cancer research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
